- Naftoflavone as a model ligand of the active site of CYP3A2003 | Faculty of Science
- Naftoflavone as a model ligand of the active site of CYP3A2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Influence of CYP3A Metabolizer Status on the Pharmacokinetics and Pharmacodynamics of Amiodarone2000 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity2017 | Faculty of Pharmacy in Hradec Králové
- Monepantel induces hepatic cytochromes p450 in sheep in vitro and in vivo2015 | Faculty of Pharmacy in Hradec Králové
- How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?2017 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- alfa-naftoflavon jako modelový ligand aktivního centra cytochromu P450 CYP3A4 a CYP3A62001 | Faculty of Science
- U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells2014 | Faculty of Pharmacy in Hradec Králové
- Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH: Cytochrome P450 reductase null mouse2007 | Faculty of Science
- The Effect of New Lipophilic Chelators on the Activities of Cytosolic Reductases and P450 Cytochromes Involved in the Metabolism of Anthracycline Antibiotics: Studies in Vitro2004 | First Faculty of Medicine
- Characterization of enzymes responsible for biotransformation of the new antileukotrienec drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes2004 | Faculty of Pharmacy in Hradec Králové
- alpha-naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A62001 | Faculty of Science
- alpha-naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A62001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- alfa-naftoflavon jako modelový ligand aktivního centra cytochromu P450 CYP3A4 a CYP3A62001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions2017 | Faculty of Pharmacy in Hradec Králové
- Effect of standardized cranberry extract on the activity and expression of selected biotransformation enzymes in rat liver and intestine2014 | Faculty of Pharmacy in Hradec Králové
- The inhibitory effects of beta-caryophyllene, beta-caryophyllene oxide and alpha-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro2017 | Faculty of Pharmacy in Hradec Králové
- Effect of Endocannabinoid Oleamide on Rat and Human Liver Cytochrome P450 Enzymes in In Vitro and In Vivo Models2018 | Faculty of Pharmacy in Hradec Králové
- Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism2016 | Faculty of Science
- Role of rat cytochromes P450 in the oxidation of 17α-ethinylestradiol2014 | Faculty of Science
- Predictors of Irinotecan Toxicity and Efficacy in Treatment of Metastatic Colorectal Cancer2012 | Faculty of Medicine in Hradec Králové
- Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems2020 | Faculty of Science, Second Faculty of Medicine
- Age-Related Changes in Hepatic Activity and Expression of Detoxification Enzymes in Male Rats2013 | Faculty of Pharmacy in Hradec Králové
- Mathematical Models in the Description of Pregnane X Receptor (PXR)-Regulated Cytochrome P450 Enzyme Induction2018 | Faculty of Science, Faculty of Pharmacy in Hradec Králové
- The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN (TM)) Mice and Pure Enzymes2015 | Faculty of Science
- Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity2015 | Faculty of Pharmacy in Hradec Králové
- Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model2011 | Second Faculty of Medicine
- Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine2019 | Faculty of Science
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine